American Association for the Advancement of Science, Science Translational Medicine, 601(13), 2021
DOI: 10.1126/scitranslmed.abc3911
Full text: Unavailable
A20 represents an immune checkpoint in lung adenocarcinomas, and its loss may be compensated by targeting the TBK1–STAT1–PD-L1 axis.